These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32053465)

  • 21. High dose psilocybin is associated with positive subjective effects in healthy volunteers.
    Nicholas CR; Henriquez KM; Gassman MC; Cooper KM; Muller D; Hetzel S; Brown RT; Cozzi NV; Thomas C; Hutson PR
    J Psychopharmacol; 2018 Jul; 32(7):770-778. PubMed ID: 29945469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.
    Barrett FS; Johnson MW; Griffiths RR
    J Psychopharmacol; 2015 Nov; 29(11):1182-90. PubMed ID: 26442957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress or Pathology? Differential Diagnosis and Intervention Criteria for Meditation-Related Challenges: Perspectives From Buddhist Meditation Teachers and Practitioners.
    Lindahl JR; Cooper DJ; Fisher NE; Kirmayer LJ; Britton WB
    Front Psychol; 2020; 11():1905. PubMed ID: 32849115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glossolalia: a contemporary mystical experience.
    Pattison EM; Casey RL
    Int Psychiatry Clin; 1969; 5(4):133-48. PubMed ID: 4892136
    [No Abstract]   [Full Text] [Related]  

  • 25. Corrigendum: Mystical and Other Alterations in Sense of Self: An Expanded Framework for Studying Nonordinary Experiences.
    Perspect Psychol Sci; 2022 Mar; 17(2):614. PubMed ID: 35073216
    [No Abstract]   [Full Text] [Related]  

  • 26. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later.
    Griffiths R; Richards W; Johnson M; McCann U; Jesse R
    J Psychopharmacol; 2008 Aug; 22(6):621-32. PubMed ID: 18593735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mystical experience and schizophrenia.
    Buckley P
    Schizophr Bull; 1981; 7(3):516-21. PubMed ID: 7280578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The crystal globe: emotional empathy and the transformation of self.
    Burris CT; Rempel JK
    Conscious Cogn; 2012 Sep; 21(3):1526-32. PubMed ID: 22726694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The serotonergic system and mysticism: could LSD and the nondrug-induced mystical experience share common neural mechanisms?
    Goodman N
    J Psychoactive Drugs; 2002; 34(3):263-72. PubMed ID: 12422936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland.
    Kangaslampi S; Hausen A; Rauteenmaa T
    J Psychoactive Drugs; 2020; 52(4):309-318. PubMed ID: 32511073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ramakrishna and the Clinic of Paradox.
    Dias PH; Safra G
    J Relig Health; 2016 Dec; 55(6):1835-49. PubMed ID: 26423064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A feature-based approach to the comparative study of "nonordinary" experiences.
    Taves A; Barlev M
    Am Psychol; 2023 Jan; 78(1):50-61. PubMed ID: 35201784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy.
    Hendricks PS
    Int Rev Psychiatry; 2018 Aug; 30(4):331-342. PubMed ID: 30260256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effects of "The Work" meditation technique on psychological scales among a non-clinical sample].
    Mitnik I; Lev-Ari S
    Harefuah; 2015 Jan; 154(1):16-20, 70, 69. PubMed ID: 25796669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neural correlates of mystical experience.
    Cristofori I; Bulbulia J; Shaver JH; Wilson M; Krueger F; Grafman J
    Neuropsychologia; 2016 Jan; 80():212-220. PubMed ID: 26631541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mysticism and psychosis: the fate of Ben Zoma.
    Greenberg D; Witztum E; Buchbinder JT
    Br J Med Psychol; 1992 Sep; 65 ( Pt 3)():223-35. PubMed ID: 1390356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings.
    Pallavicini C; Cavanna F; Zamberlan F; de la Fuente LA; Ilksoy Y; Perl YS; Arias M; Romero C; Carhart-Harris R; Timmermann C; Tagliazucchi E
    J Psychopharmacol; 2021 Apr; 35(4):406-420. PubMed ID: 33567945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique.
    Mosurinjohn S; Roseman L; Girn M
    Front Psychiatry; 2023; 14():1077311. PubMed ID: 37181886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring Emptiness and its Effects on Non-attachment, Mystical Experiences, and Psycho-spiritual Wellbeing: A Quantitative and Qualitative Study of Advanced Meditators.
    Van Gordon W; Shonin E; Dunn TJ; Sapthiang S; Kotera Y; Garcia-Campayo J; Sheffield D
    Explore (NY); 2019; 15(4):261-272. PubMed ID: 30660506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The psychopathology of mystical and religious conversion experiences in psychiatric patients. A phenomenological study. II.
    Sedman G; Hopkinson G
    Confin Psychiatr; 1966; 9(2):65-77. PubMed ID: 5960432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.